The U.S. Army is approaching a significant milestone in its effort to identify and mitigate brain injuries linked to blast exposure, with about 97% of soldiers having used the Neurocognitive Assessment Tool, according to the service's top leader overseeing safety and occupational health. The figure suggests that a once-niche medical screening process is becoming embedded in routine military practice, reflecting growing concern inside the force over the cumulative effects of blast overpressure and repeated low-level blast exposure.
The development is notable because the Army has spent years trying to move beyond a narrow focus on visible battlefield trauma and toward earlier detection of less obvious neurological harm. Blast overpressure, which can occur during weapons firing, training exercises, and combat operations, has increasingly been associated with headaches, memory issues, concentration problems, sleep disruption and other symptoms that may not appear immediately after exposure. Low-level blast exposure, in particular, has emerged as a concern because its effects can accumulate over time and may be difficult to distinguish from stress, fatigue or other operational demands.
Readiness and Brain Health
The near-universal use of the assessment tool indicates that the Army is trying to normalize brain health screening in the same way it has long treated hearing tests, physical fitness checks and other readiness measures. That shift matters because military medicine has historically struggled to identify neurological injury early enough to prevent longer-term consequences. By making the assessment widely available and widely used, the Army is signaling that cognitive health is now part of force protection, not simply post-injury care.
The tool itself is designed to help medical professionals and commanders identify changes in cognitive performance that may warrant further evaluation. In practice, that can support decisions about rest, treatment, return-to-duty timelines and exposure management. The broader goal is not merely to diagnose injury after the fact, but to create a system that can detect warning signs before they become disabling.
Officials have increasingly framed this work as essential to operational effectiveness. A force that cannot reliably track the neurological effects of training and combat exposure risks degrading performance over time, even if individual injuries are not dramatic enough to trigger immediate concern. The Army's emphasis on occupational health reflects that reality: brain injury prevention is being treated as a readiness issue with implications for retention, deployment and long-term veteran care.
Blast Exposure Concerns
The Army's focus on blast overpressure comes amid a wider reassessment across the U.S. military of the hidden costs of repeated exposure to explosive forces. While major concussive events have long been recognized as dangerous, medical researchers and defense officials have increasingly examined the possible effects of smaller, repeated exposures that may occur during routine training or weapons use. That concern has sharpened as the military seeks to preserve combat capability while reducing avoidable harm.
The challenge is partly scientific and partly institutional. Neurological symptoms can be subtle, delayed or influenced by many other factors, making it difficult to establish a clear line between exposure and injury in every case. Yet the scale of Army participation in the Neurocognitive Assessment Tool suggests the service is moving ahead with a precautionary approach rather than waiting for perfect certainty. In a large force, even modest improvements in early detection can have significant consequences for health outcomes and readiness.
The milestone also points to a broader cultural change. For years, troops and leaders often viewed cognitive symptoms as something to be endured or minimized. The Army's current posture suggests a stronger institutional willingness to treat such symptoms as legitimate medical concerns. That is especially important in environments where personnel may be reluctant to report problems for fear of being sidelined or seen as less deployable.
What Comes Next
Reaching 97% usage is not the end state; it is a sign that the Army now faces the harder task of turning data into action. Screening only matters if it leads to timely follow-up, meaningful clinical interpretation and practical changes in exposure management. The service will need to ensure that the tool is used consistently, that results are understood in context and that soldiers who need care are not lost in the system.
The Army's next challenge is likely to be balancing operational demands with medical caution. Training and combat readiness still require live-fire exercises, heavy weapons use and other activities that can generate blast exposure. The question is how to preserve those capabilities while reducing the risk of cumulative neurological harm. That will require not just testing, but policy changes, command awareness and continued research.
For now, the near-complete adoption of the Neurocognitive Assessment Tool marks an important institutional benchmark. It suggests the Army has accepted that brain health is inseparable from readiness and that the effects of blast exposure must be monitored with the same seriousness as other occupational hazards. In a force built on physical endurance and technical precision, that may prove to be one of the most consequential shifts in military health policy in years.